Is a complete GSK research report available?

No complete published report is available for GSK plc (GSK) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

GSK plc (GSK)

NYSE: GSK · USD

$48.7

-2.24 (-4.4%)· Recorded snapshot

Market cap	97.9B
Revenue (ttm)	44.5B
Net income (ttm)	5.8B
EPS (ttm)	$3.13
Shares out	4B
P/E (trailing)	15.5x
P/E (forward)	8.9x
Dividend	$1.79 (3.67%)
Volume	7,610,030
Beta	0.28

Market data

Price

Recent price action with selectable time range.

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Metric	Value
Amount currency	USD
CIK code	0001131399
Company name	GSK plc
Country	United Kingdom
Country code	US
CUSIP number	37733W204
Earnings date	2026-10-28
Earnings time	bmo
Employees	66,841
Employees change	-1,788
Employees growth	-2.61%
Enterprise value	$117.5B
Exchange	NYSE
Financial currency	GBP
Financial report date	2026-09-30
First seen	2026-05-09
Fiscal year end	December
Founded	1715
Industry	Drug Manufacturers - General
Is primary listing	No
Is SPAC	No
ISIN number	US37733W2044
Last 10-K release date	2026-03-06
Last earnings date	2026-10-28
Last refreshed	2026-10-28
Last stock split date	2022-07-19
Last stock split type	Reverse
Market cap	$97.9B
Market cap category	Large-Cap
Next earnings date	2027-02-03
Options	Yes
Price	$48.70
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	GSK
Website	https://www.gsk.com

Metric

Value

Amount currency

USD

CIK code

0001131399

Company name

GSK plc

Country

United Kingdom

Country code

CUSIP number

37733W204

Earnings date

2026-10-28

Earnings time

bmo

Employees

66,841

Employees change

-1,788

Employees growth

-2.61%

Enterprise value

$117.5B

Exchange

NYSE

Financial currency

GBP

Financial report date

2026-09-30

First seen

2026-05-09

Fiscal year end

December

Founded

1715

Industry

Drug Manufacturers - General

Is primary listing

Is SPAC

ISIN number

US37733W2044

Last 10-K release date

2026-03-06

Last earnings date

2026-10-28

Last refreshed

2026-10-28

Last stock split date

2022-07-19

Last stock split type

Reverse

Market cap

$97.9B

Market cap category

Large-Cap

Next earnings date

2027-02-03

Options

Yes

Price

$48.70

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

GSK

Website

https://www.gsk.com

Metric	Value
Adjusted P/E ratio	10.32x
Average P/E ratio (10Y)	21.56x
Average P/E ratio (3Y)	16.33x
Average P/E ratio (5Y)	13.77x
Earnings yield	6.44%
EV/Earnings	21.15x
EV/EBIT	12.24x
EV/EBITDA	9.01x
EV/FCF	12.37x
EV/Sales	2.74x
FCF / EV yield	8.08%
FCF yield	9.63%
Forward EV/Sales	2.62x
Forward P/E	8.92x
Forward P/S	2.2x
Graham number	26.82075
Graham upside	-45.12%
Industry forward P/E	18.47x
Industry P/E	35.8x
Lynch fair value	$13.76
Lynch upside	-71.84%
P/(FCF - SBC) ratio	10.94x
P/(OCF - SBC) ratio	9.02x
P/B ratio	4.21x
P/E ratio	15.53x
P/FCF ratio	10.39x
P/OCF ratio	8.65x
P/S ratio	2.3x
Price/EBITDA ratio	7.57x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Adjusted P/E ratio

10.32x

Average P/E ratio (10Y)

21.56x

Average P/E ratio (3Y)

16.33x

Average P/E ratio (5Y)

13.77x

Earnings yield

6.44%

EV/Earnings

21.15x

EV/EBIT

12.24x

EV/EBITDA

9.01x

EV/FCF

12.37x

EV/Sales

2.74x

FCF / EV yield

8.08%

FCF yield

9.63%

Forward EV/Sales

2.62x

Forward P/E

8.92x

Forward P/S

2.2x

Graham number

26.82075

Graham upside

-45.12%

Industry forward P/E

18.47x

Industry P/E

35.8x

Lynch fair value

$13.76

Lynch upside

-71.84%

P/(FCF - SBC) ratio

10.94x

P/(OCF - SBC) ratio

9.02x

P/B ratio

4.21x

P/E ratio

15.53x

P/FCF ratio

10.39x

P/OCF ratio

8.65x

P/S ratio

2.3x

Price/EBITDA ratio

7.57x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
EBIT margin	22.41%
EBITDA margin	30.44%
Effective tax rate	10.42%
FCF margin	22.13%
Gross margin	72.82%
Operating margin	22.41%
Pretax margin	16.05%
Profit margin	12.97%
Profit per employee	$86,421
Profitable quarters	7
Profitable years	23
Revenue per employee	$666,241
ROA	7.06%
ROA (5Y)	7.23%
ROCE	14.74%
ROE	28.27%
ROE (5Y)	32.1%
ROIC	18.84%
ROIC (5Y)	22.54%
SBC / revenue	1.11%
Tax / revenue	1.67%

Metric

Value

EBIT margin

22.41%

EBITDA margin

30.44%

Effective tax rate

10.42%

FCF margin

22.13%

Gross margin

72.82%

Operating margin

22.41%

Pretax margin

16.05%

Profit margin

12.97%

Profit per employee

$86,421

Profitable quarters

Profitable years

Revenue per employee

$666,241

ROA

7.06%

ROA (5Y)

7.23%

ROCE

14.74%

ROE

28.27%

ROE (5Y)

32.1%

ROIC

18.84%

ROIC (5Y)

22.54%

SBC / revenue

1.11%

Tax / revenue

1.67%

Metric	Value
EPS growth	-19.73%
EPS growth (Q)	-22.81%
EPS growth (QoQ)	254.21%
EPS growth 10Y	30.09%
EPS growth 3Y	-10.34%
EPS growth 5Y	0%
EPS growth years	1
FCF growth	14.66%
FCF growth (Q)	27.42%
FCF growth (QoQ)	3.09%
FCF growth 3Y	20.79%
FCF growth 5Y	1.32%
Gross profit growth	4.83%
Gross profit growth (Q)	3%
Gross profit growth 3Y	5.31%
Gross profit growth 5Y	6.15%
Net income growth	-20.81%
Net income growth (Q)	-23.35%
Net income growth (QoQ)	254.71%
Net income growth 3Y	-10.52%
Net income growth 5Y	0.18%
Net income growth years	1
OCF growth	14.45%
OCF growth (Q)	26.42%
OCF growth (QoQ)	4.42%
OCF growth 10Y	5.94%
OCF growth 3Y	17.65%
OCF growth 5Y	2.09%
Operating income growth	-14.77%
Operating income growth (Q)	-30.99%
Operating income growth 3Y	-0.36%
Operating income growth 5Y	2.77%
Revenue growth	4.28%
Revenue growth (Q)	3.98%
Revenue growth (QoQ)	5.68%
Revenue growth 10Y	2.35%
Revenue growth 3Y	4.2%
Revenue growth 5Y	4.94%
Revenue growth quarters	7
Revenue growth years	5

Metric

Value

EPS growth

-19.73%

EPS growth (Q)

-22.81%

EPS growth (QoQ)

254.21%

EPS growth 10Y

30.09%

EPS growth 3Y

-10.34%

EPS growth 5Y

EPS growth years

FCF growth

14.66%

FCF growth (Q)

27.42%

FCF growth (QoQ)

3.09%

FCF growth 3Y

20.79%

FCF growth 5Y

1.32%

Gross profit growth

4.83%

Gross profit growth (Q)

Gross profit growth 3Y

5.31%

Gross profit growth 5Y

6.15%

Net income growth

-20.81%

Net income growth (Q)

-23.35%

Net income growth (QoQ)

254.71%

Net income growth 3Y

-10.52%

Net income growth 5Y

0.18%

Net income growth years

OCF growth

14.45%

OCF growth (Q)

26.42%

OCF growth (QoQ)

4.42%

OCF growth 10Y

5.94%

OCF growth 3Y

17.65%

OCF growth 5Y

2.09%

Operating income growth

-14.77%

Operating income growth (Q)

-30.99%

Operating income growth 3Y

-0.36%

Operating income growth 5Y

2.77%

Revenue growth

4.28%

Revenue growth (Q)

3.98%

Revenue growth (QoQ)

5.68%

Revenue growth 10Y

2.35%

Revenue growth 3Y

4.2%

Revenue growth 5Y

4.94%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	$-2B
Depreciation and amortization	$3.6B
EBIT	$10B
EBITDA	$13.6B
EPS	$3.13
FCF per share	$2.46
Financing cash flow	$2.6B
Free cash flow	$9.9B
Free cash flow minus SBC	$9.4B
Gross profit	$32.4B
Income taxes	$744.8M
Investing cash flow	$-14.5B
Net borrowing	$8.4B
Net cash flow	$-103.6M
Net income	$5.8B
Operating cash flow minus SBC	$11.4B
Operating income	$10B
Revenue	$44.5B
Stock-based compensation	$496.5M

Metric

Value

Capital expenditures

$-2B

Depreciation and amortization

$3.6B

EBIT

$10B

EBITDA

$13.6B

EPS

$3.13

FCF per share

$2.46

Financing cash flow

$2.6B

Free cash flow

$9.9B

Free cash flow minus SBC

$9.4B

Gross profit

$32.4B

Income taxes

$744.8M

Investing cash flow

$-14.5B

Net borrowing

$8.4B

Net cash flow

$-103.6M

Net income

$5.8B

Operating cash flow minus SBC

$11.4B

Operating income

$10B

Revenue

$44.5B

Stock-based compensation

$496.5M

Metric	Value
Book value per share	$6.21
Debt / EBITDA	2.28
Debt / equity	1.29
Debt / FCF	3.19
Goodwill	$10.9B
Interest coverage	10.54
Long-term assets	$71.4B
Long-term liabilities	$43.3B
Net cash (debt)	$-27.5B
Net cash / market cap	-26.85%
Net debt / EBITDA	2.03
Net debt / equity	1.13
Net debt / FCF	2.79
Piotroski F-Score	6
Property, plant and equipment	$13.5B
Shareholders' equity	$24.4B
Tangible book value	$-19.4B
Tangible book value per share	$-4.85
Total assets	$95.2B
Total cash	$3.9B
Total debt	$31.5B
Total liabilities	$70.8B
WACC	5.06%

Metric

Value

Book value per share

$6.21

Debt / EBITDA

2.28

Debt / equity

1.29

Debt / FCF

3.19

Goodwill

$10.9B

Interest coverage

10.54

Long-term assets

$71.4B

Long-term liabilities

$43.3B

Net cash (debt)

$-27.5B

Net cash / market cap

-26.85%

Net debt / EBITDA

2.03

Net debt / equity

1.13

Net debt / FCF

2.79

Piotroski F-Score

Property, plant and equipment

$13.5B

Shareholders' equity

$24.4B

Tangible book value

$-19.4B

Tangible book value per share

$-4.85

Total assets

$95.2B

Total cash

$3.9B

Total debt

$31.5B

Total liabilities

$70.8B

WACC

5.06%

Metric	Value
Asset turnover	0.5
Current assets	$23.8B
Current liabilities	$27.6B
Current ratio	0.86
Inventory turnover	1.47
Net working capital	$-5B
Quick ratio	0.55
Working capital	$-3.8B
Working capital turnover	-14.1

Metric

Value

Asset turnover

0.5

Current assets

$23.8B

Current liabilities

$27.6B

Current ratio

0.86

Inventory turnover

1.47

Net working capital

$-5B

Quick ratio

0.55

Working capital

$-3.8B

Working capital turnover

-14.1

Metric	Value
Buyback yield / dilution	1.41%
Dividend growth	10.29%
Dividend growth (10Y)	-4.01%
Dividend growth (3Y)	9.74%
Dividend growth (5Y)	-7.99%
Dividend growth years	2
Dividend payment date	2026-10-08
Dividend payment years	54
Dividend payout frequency	Quarterly
Dividend per share	$1.79
Dividend yield	3.67%
Ex-dividend date	2026-08-14
FCF payout ratio	72.55%
Last dividend	$0.44
Payout ratio	57.01%
Shareholder yield	5.07%

Metric

Value

Buyback yield / dilution

1.41%

Dividend growth

10.29%

Dividend growth (10Y)

-4.01%

Dividend growth (3Y)

9.74%

Dividend growth (5Y)

-7.99%

Dividend growth years

Dividend payment date

2026-10-08

Dividend payment years

Dividend payout frequency

Quarterly

Dividend per share

$1.79

Dividend yield

3.67%

Ex-dividend date

2026-08-14

FCF payout ratio

72.55%

Last dividend

$0.44

Payout ratio

57.01%

Shareholder yield

5.07%

Metric	Value
10Y price change	-3.69%
10Y return CAGR	6.44%
10Y total return	86.6%
150-day SMA	$51.56
15Y price change	-13.01%
15Y return CAGR	5.45%
15Y total return	121.7%
1D price change	-4.4%
1M price change	-1.18%
1M total return	-1.18%
1W price change	-3.89%
1W total return	-3.89%
1Y price change	11.1%
1Y return CAGR	14.98%
1Y total return	14.97%
20-day SMA	$48.49
200-day SMA	$52.36
20Y price change	-26.94%
20Y return CAGR	4.41%
20Y total return	136.88%
3M price change	-6.39%
3M total return	-5.56%
3Y price change	40.8%
3Y return CAGR	16.48%
3Y total return	58.05%
50-day SMA	$49.56
50-day SMA vs 200-day SMA	50under200
52-week high	$61.70
52-week high date	2026-02-18
52-week low	$42.89
52-week low date	2025-10-28
5Y price change	-3.69%
5Y return CAGR	7.61%
5Y total return	44.26%
6M price change	-10.25%
6M total return	-8.66%
All-time high	$74.98
All-time high date	2007-04-20
All-time low	$28.47
All-time low date	2022-09-26
Average true range (ATR)	$1.16
Average volume	5.9M
Beta (5Y)	0.28
Change from 52-week high	-21.06%
Change from 52-week low	13.56%
Change from all-time high	-35.1%
Change from all-time low	70.95%
Change from open	2.46%
Day's gap	-6.69%
Dollar volume	$370.6M
High price	$49.31
Low price	$47.37
Monthly RSI	53.76
Open price	$47.53
Position in 52-week range	68.56%
Premarket change	-6.32%
Premarket close	$50.94
Premarket price	$47.72
Premarket volume	992.1K
Previous close	$50.94
Price vs 150-day SMA	-5.62%
Price vs 20-day SMA	0.35%
Price vs 200-day SMA	-7.06%
Price vs 50-day SMA	-1.82%
Relative volume	1.29
RSI	46.46
Sharpe ratio	0.51
Sharpe ratio (3Y)	0.52
Sharpe ratio (5Y)	0.28
Sortino ratio	1.03
Sortino ratio (3Y)	1
Sortino ratio (5Y)	0.64
Volume	7.6M
Weekly RSI	46.2
YTD price change	-0.77%
YTD total return	1.78%

Metric

Value

10Y price change

-3.69%

10Y return CAGR

6.44%

10Y total return

86.6%

150-day SMA

$51.56

15Y price change

-13.01%

15Y return CAGR

5.45%

15Y total return

121.7%

1D price change

-4.4%

1M price change

-1.18%

1M total return

-1.18%

1W price change

-3.89%

1W total return

-3.89%

1Y price change

11.1%

1Y return CAGR

14.98%

1Y total return

14.97%

20-day SMA

$48.49

200-day SMA

$52.36

20Y price change

-26.94%

20Y return CAGR

4.41%

20Y total return

136.88%

3M price change

-6.39%

3M total return

-5.56%

3Y price change

40.8%

3Y return CAGR

16.48%

3Y total return

58.05%

50-day SMA

$49.56

50-day SMA vs 200-day SMA

50under200

52-week high

$61.70

52-week high date

2026-02-18

52-week low

$42.89

52-week low date

2025-10-28

5Y price change

-3.69%

5Y return CAGR

7.61%

5Y total return

44.26%

6M price change

-10.25%

6M total return

-8.66%

All-time high

$74.98

All-time high date

2007-04-20

All-time low

$28.47

All-time low date

2022-09-26

Average true range (ATR)

$1.16

Average volume

5.9M

Beta (5Y)

0.28

Change from 52-week high

-21.06%

Change from 52-week low

13.56%

Change from all-time high

-35.1%

Change from all-time low

70.95%

Change from open

2.46%

Day's gap

-6.69%

Dollar volume

$370.6M

High price

$49.31

Low price

$47.37

Monthly RSI

53.76

Open price

$47.53

Position in 52-week range

68.56%

Premarket change

-6.32%

Premarket close

$50.94

Premarket price

$47.72

Premarket volume

992.1K

Previous close

$50.94

Price vs 150-day SMA

-5.62%

Price vs 20-day SMA

0.35%

Price vs 200-day SMA

-7.06%

Price vs 50-day SMA

-1.82%

Relative volume

1.29

RSI

46.46

Sharpe ratio

0.51

Sharpe ratio (3Y)

0.52

Sharpe ratio (5Y)

0.28

Sortino ratio

1.03

Sortino ratio (3Y)

Sortino ratio (5Y)

0.64

Volume

7.6M

Weekly RSI

46.2

YTD price change

-0.77%

YTD total return

1.78%

Metric	Value
Float	3.9B
Float percentage	96.9%
Shares change (QoQ)	0.23%
Shares change (YoY)	-1.41%
Shares held by insiders	0.06%
Shares held by institutions	84.57%
Shares outstanding	4B
Short % of shares	0.74%
Short ratio	4.8 days

Metric

Value

Float

3.9B

Float percentage

96.9%

Shares change (QoQ)

0.23%

Shares change (YoY)

-1.41%

Shares held by insiders

0.06%

Shares held by institutions

84.57%

Shares outstanding

Short % of shares

0.74%

Short ratio

4.8 days

Metric	Value
Page views	293

Metric

Value

Page views

293

GSK plc (GSK)

Price

Financial snapshot

Fair-value bridge

Latest news · GSK

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GSK indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on GSK

Frequently asked questions